23
Non-classical neurotransmitters Nitric Oxide Peptides A TP and Adenosine Nitric Oxide Synthesis and Function

Non-Classical Neurotransmission

Embed Size (px)

Citation preview

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 1/29

Non-classical neurotransmitters

Nitric Oxide

PeptidesATP and Adenosine

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 2/29

Nitric Oxide Synthesis and Function

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 3/29

Can NO be consider an unconventional neurotransmitter

NO acts as a retrograde messenger during LTP in the hippocampus and LTD in

cerebellum and has been involved in neurotoxicity mediated by NMDA receptors

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 4/29

Non-classical neurotransmitters

Nitric Oxide 

Peptides ATP and Adenosine

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 5/29Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 6/29

Peptides are synthesized in the cell body and released from large dense core vesicle

Peptides co-localize with other 

neurotransmitters

Peptides are transported

in vesicles along withprocessing enzymes

as pro-peptides by fast

axonal transport

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 7/29

Nolte J, Integrated Neuroscienc

Peptides use different types of synaptic vesicles and release mechanis

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 8/29

FIGURE 20-4: Neuropeptides and conventional neurotransmitters are released from different parts of the nerve terminal

neuromuscular junction containing both large dense-core vesicles (containing the neuropeptide SCP) and small synaptic vesicle

(containing acetylcholine) was stimulated for 30 min at 12 Hz (3.5 s every 7 s). Depletion of the small clear vesicles at the muscleface and of the peptide granules at the nonmuscle face of the nerve terminal was observed. After stimulation, there was an incre

in the number of large dense-core vesicles within one vesicle diameter of the membrane. (Adapted from Karhunen et al., 2001.)

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 9/29

Biosynthesis of Peptides 

Multiple peptides can be derived from the same gene. Peptides are synthesized as lo

precursor molecules and then cleaved by specific proteases

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 10/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 11/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 12/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 13/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 14/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

FIGURE 20-10: Serpentine (seven-transmembrane-domain) receptors for peptides have binding for their peptide ligands

within the membrane and in the NH2-terminal loop. 

G-protein

Neuropeptide Receptors 

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 15/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

Function of Neuropeptides: NPY 

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 16/29

Role of leptin and hypothalamic peptides in the control of appetit

WT vs. ob/ob

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 17/29

Complex control of appetite involves several hypothalamic peptid

 Adapted from Flier, Cell, 116, 342

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 18/29

  Non-classical neurotransmitter

Nitric Oxide

PeptidesATP and Adenosine(purinergic neurotransmitters)

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 19/29

Purinergic neurotransmitters: Adenosine and ATP

ATP, ApnA

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 20/29

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 21/29

Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.

Purine release and metabolism 

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 22/29

Nucleotide degradation and salvage pathway

Lesch-Nyhan syndrome

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 23/29

The structure of the different nucleoside transporters is not known but

they transport nucleoside analogs that act as therapeutic drugs for the

treatment of cancer or AIDS (AZT).

Adenosine produces vasodilation and dipyridamole, an inhibitor of 

adenosine transporter, increases its levels extracellularly and thus, isused clinically to produce coronary vasodilation

ENTs CNTs

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 24/29

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 25/29

A1 agonist binding (3H-CPX)

A1 is coupled to Gi/o and activation has been

implicated in the anxiolytic, anticonvulsant,

analgesic and sedative actions of adenosine.

Adenosine A1 receptor agonists have being

proposed as neuroprotective agents in the

treatment of stroke because binding of adenosto presynaptic A1 receptors inhibits glutamate

release while activation of postsynaptic A1 

receptors opens K+ and Cl- channels and

hyperpolarizes the cell. Also, A1R activation

inhibits microglia activation.

A t f ti

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 26/29

A2A immunostaining

A2A is highly expressed in dorsal

striatum, nucleus accumbens and

olfactory tubercle.

In the straitum, A2A , which is couto Gs inhibits D2R action.

D2R is coupled to Gi, therefore A

antagonists are being tested as

potential drugs for the treatment

Parkinson’s disease. 

Methylxanthines such as caffeineas antagonists of A2A receptors

A2A receptor function

A2B receptors are present in endothelial cells, where they regulate vascular 

permeability. Both A2A and A2B receptors contribute to vasodilation.

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 27/29

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 28/29

Different role of purinergic receptors in synaptic plasticity

7/29/2019 Non-Classical Neurotransmission

http://slidepdf.com/reader/full/non-classical-neurotransmission 29/29